Kheiron Medical Technologies
is a leading applied science company – transforming cancer diagnostics through the power of deep learning.
Materials
Learn
Cras justo odio, dapibus ac facilisis in, egestas eget quam. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante venenatis dapibus posuere velit aliquet.
Nullam quis risus eget urna mollis ornare vel eu leo.
Resources
Science
Cras justo odio, dapibus ac facilisis in, egestas eget quam. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante venenatis dapibus posuere velit aliquet. Nullam quis risus eget urna mollis ornare vel eu leo.
Challenges
Mia addresses the key problems facing breast screening services
Condimentum Cras
Praesent commodo cursus magna, vel scelerisque nisl consectetur et. Maecenas sed diam eget risus varius blandit sit amet non magna. Etiam porta sem malesuada magna mollis euismod.
Adipiscing Nullam
Cras justo odio, dapibus ac facilisis in, egestas eget quam. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante venenatis dapibus posuere velit aliquet.
Ullamcorper Adipiscing
Cras justo odio, dapibus ac facilisis in, egestas eget quam. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante venenatis dapibus posuere velit aliquet.
Ullamcorper Adipiscing
Cras justo odio, dapibus ac facilisis in, egestas eget quam. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante venenatis dapibus posuere velit aliquet.
Our vision is that Mia should allow every woman in the UK to experience accurate, fast, safe breast screening services regardless of geography, ethnicity or age. This award will help us bring our technology rapidly and safely into the NHS across the UK.
Dr. Peter Kecskemethy
Kheiron Medical Technologies
Co-Founder CEO
Related products
Latest articles
PR
21st March 2024
12% more breast cancers detected with potential workload savings of 30% in the UK’s first prospective evaluation of breast screening AI
“It’s a lifesaver, it’s a life changer,” says one of the first women in the UK to have her breast cancer picked up by Kheiron Medical’s technology called Mia® An artific…
Read more
Abstract
4th January 2023
Abstract: Post-market real-world data demonstrating use of an AI system as an extra reader to augment breast cancer detection without unnecessary recalls
Purpose To demonstrate real-world post-market benefit of artificial intelligence (AI) as an extra reader in breast cancer screening (BCS). Method A commercially available AI system…
Read more
Abstract
4th January 2023
Abstract: Safe and effective integration of AI as supporting reader in double reading breast cancer screening
Purpose To evaluate the effectiveness and practical implications of a novel workflow of using AI as a supporting reader for the detection of breast cancer in double reading screeni…
Read moreMeet the team
Team Spotlight
TOBIAS RIJKEN
Co-Founder & CTO
KAREN FITCHETT
Vice President of Products
DR. CHRISTOPHER AUSTIN
Chief Medical Officer
ALEX HAMLOW
Chief Commercial Officer